Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE10.6900
- TODAY'S CHANGE (%)-0.1200 (-1.1101%)
- Bid / Lots10.6900/ 1
- Ask / Lots11.0000/ 11
- Open / Previous Close10.7100 / 10.8100
- Day Range
- 52 Week Range
- Volume2,802,689
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 19616 | 10.72 |
| 09:34 ET | 1900 | 10.71 |
| 09:36 ET | 620 | 10.75 |
| 09:38 ET | 2055 | 10.75 |
| 09:39 ET | 2900 | 10.745 |
| 09:41 ET | 9431 | 10.6952 |
| 09:45 ET | 8787 | 10.74 |
| 09:48 ET | 1600 | 10.73 |
| 09:50 ET | 1833 | 10.72 |
| 09:52 ET | 1784 | 10.7 |
| 09:54 ET | 3908 | 10.69 |
| 09:56 ET | 1314 | 10.68 |
| 09:57 ET | 1900 | 10.6701 |
| 09:59 ET | 1865 | 10.67 |
| 10:01 ET | 4412 | 10.645 |
| 10:03 ET | 433 | 10.64 |
| 10:06 ET | 1102 | 10.625 |
| 10:08 ET | 5844 | 10.635 |
| 10:10 ET | 9587 | 10.625 |
| 10:12 ET | 6176 | 10.64 |
| 10:14 ET | 600 | 10.64 |
| 10:15 ET | 2914 | 10.655 |
| 10:17 ET | 3829 | 10.655 |
| 10:19 ET | 2053 | 10.67 |
| 10:21 ET | 4600 | 10.675 |
| 10:24 ET | 3347 | 10.69 |
| 10:26 ET | 800 | 10.685 |
| 10:28 ET | 5574 | 10.685 |
| 10:30 ET | 6531 | 10.685 |
| 10:32 ET | 7411 | 10.665 |
| 10:33 ET | 2621 | 10.635 |
| 10:35 ET | 2512 | 10.65 |
| 10:37 ET | 5580 | 10.645 |
| 10:39 ET | 6026 | 10.615 |
| 10:42 ET | 38625 | 10.615 |
| 10:44 ET | 1899 | 10.62 |
| 10:46 ET | 5472 | 10.615 |
| 10:48 ET | 31689 | 10.615 |
| 10:50 ET | 1205 | 10.62 |
| 10:51 ET | 40319 | 10.615 |
| 10:53 ET | 18246 | 10.585 |
| 10:55 ET | 29511 | 10.6 |
| 10:57 ET | 6404 | 10.6 |
| 11:00 ET | 7748 | 10.62 |
| 11:02 ET | 100 | 10.615 |
| 11:04 ET | 5140 | 10.625 |
| 11:06 ET | 10455 | 10.61 |
| 11:08 ET | 25670 | 10.605 |
| 11:09 ET | 3767 | 10.595 |
| 11:11 ET | 100 | 10.595 |
| 11:13 ET | 3878 | 10.61 |
| 11:15 ET | 9527 | 10.595 |
| 11:18 ET | 23991 | 10.605 |
| 11:20 ET | 381 | 10.605 |
| 11:22 ET | 3504 | 10.62 |
| 11:24 ET | 8469 | 10.62 |
| 11:26 ET | 53103 | 10.625 |
| 11:27 ET | 7645 | 10.63 |
| 11:29 ET | 2165 | 10.635 |
| 11:31 ET | 8295 | 10.63 |
| 11:33 ET | 12090 | 10.645 |
| 11:36 ET | 3881 | 10.63 |
| 11:38 ET | 27326 | 10.61 |
| 11:40 ET | 400 | 10.61 |
| 11:42 ET | 12764 | 10.59 |
| 11:44 ET | 4131 | 10.605 |
| 11:45 ET | 2262 | 10.6 |
| 11:47 ET | 6033 | 10.6 |
| 11:49 ET | 6051 | 10.605 |
| 11:51 ET | 6532 | 10.605 |
| 11:54 ET | 9328 | 10.605 |
| 11:56 ET | 1835 | 10.605 |
| 11:58 ET | 14235 | 10.6 |
| 12:00 ET | 12241 | 10.605 |
| 12:02 ET | 642 | 10.61 |
| 12:03 ET | 1200 | 10.61 |
| 12:05 ET | 3684 | 10.6001 |
| 12:07 ET | 12074 | 10.6157 |
| 12:09 ET | 3200 | 10.63 |
| 12:12 ET | 2813 | 10.63 |
| 12:14 ET | 51694 | 10.67 |
| 12:16 ET | 1922 | 10.67 |
| 12:18 ET | 35448 | 10.67 |
| 12:20 ET | 8547 | 10.69 |
| 12:21 ET | 2763 | 10.695 |
| 12:23 ET | 5023 | 10.685 |
| 12:25 ET | 1248 | 10.685 |
| 12:27 ET | 7066 | 10.645 |
| 12:30 ET | 1247 | 10.64 |
| 12:32 ET | 1564 | 10.635 |
| 12:34 ET | 500 | 10.63 |
| 12:36 ET | 1195 | 10.635 |
| 12:38 ET | 10144 | 10.635 |
| 12:39 ET | 7128 | 10.655 |
| 12:41 ET | 1200 | 10.66 |
| 12:43 ET | 1300 | 10.66 |
| 12:45 ET | 2248 | 10.655 |
| 12:48 ET | 500 | 10.66 |
| 12:50 ET | 22100 | 10.67 |
| 12:52 ET | 26811 | 10.675 |
| 12:54 ET | 6980 | 10.68 |
| 12:56 ET | 6084 | 10.68 |
| 12:57 ET | 15606 | 10.68 |
| 12:59 ET | 124846 | 10.7 |
| 01:01 ET | 21886 | 10.715 |
| 01:03 ET | 100 | 10.72 |
| 01:06 ET | 734 | 10.715 |
| 01:08 ET | 6368 | 10.73 |
| 01:10 ET | 2204 | 10.735 |
| 01:12 ET | 4034 | 10.73 |
| 01:14 ET | 1321 | 10.735 |
| 01:15 ET | 548 | 10.74 |
| 01:17 ET | 600 | 10.735 |
| 01:19 ET | 600 | 10.74 |
| 01:21 ET | 12145 | 10.75 |
| 01:24 ET | 33593 | 10.756 |
| 01:26 ET | 5438 | 10.75 |
| 01:28 ET | 6544 | 10.765 |
| 01:30 ET | 700 | 10.77 |
| 01:32 ET | 20252 | 10.76 |
| 01:33 ET | 2930 | 10.7501 |
| 01:35 ET | 100 | 10.755 |
| 01:37 ET | 400 | 10.76 |
| 01:39 ET | 900 | 10.76 |
| 01:42 ET | 6971 | 10.74 |
| 01:44 ET | 2952 | 10.73 |
| 01:46 ET | 5478 | 10.735 |
| 01:48 ET | 1000 | 10.74 |
| 01:50 ET | 1096 | 10.735 |
| 01:51 ET | 3606 | 10.725 |
| 01:53 ET | 500 | 10.725 |
| 01:55 ET | 18287 | 10.72 |
| 01:57 ET | 3715 | 10.695 |
| 02:00 ET | 306 | 10.7 |
| 02:02 ET | 4567 | 10.695 |
| 02:04 ET | 5634 | 10.7 |
| 02:06 ET | 3791 | 10.71 |
| 02:08 ET | 1000 | 10.72 |
| 02:09 ET | 22157 | 10.705 |
| 02:11 ET | 2518 | 10.7006 |
| 02:13 ET | 1050 | 10.7 |
| 02:15 ET | 1438 | 10.7 |
| 02:18 ET | 14503 | 10.69 |
| 02:20 ET | 1661 | 10.705 |
| 02:22 ET | 400 | 10.705 |
| 02:24 ET | 1165 | 10.71 |
| 02:26 ET | 17746 | 10.695 |
| 02:27 ET | 1546 | 10.71 |
| 02:29 ET | 500 | 10.71 |
| 02:31 ET | 9449 | 10.7 |
| 02:33 ET | 1200 | 10.69 |
| 02:36 ET | 2770 | 10.695 |
| 02:38 ET | 4147 | 10.6801 |
| 02:40 ET | 1027 | 10.6849 |
| 02:42 ET | 9312 | 10.66 |
| 02:44 ET | 9183 | 10.66 |
| 02:45 ET | 8923 | 10.68 |
| 02:47 ET | 7422 | 10.67 |
| 02:49 ET | 2573 | 10.675 |
| 02:51 ET | 2976 | 10.675 |
| 02:54 ET | 12162 | 10.675 |
| 02:56 ET | 6797 | 10.685 |
| 02:58 ET | 32887 | 10.7 |
| 03:00 ET | 2870 | 10.705 |
| 03:02 ET | 2109 | 10.7 |
| 03:03 ET | 21532 | 10.715 |
| 03:05 ET | 1615 | 10.72 |
| 03:07 ET | 7285 | 10.7237 |
| 03:09 ET | 2658 | 10.725 |
| 03:12 ET | 20978 | 10.72 |
| 03:14 ET | 15490 | 10.725 |
| 03:16 ET | 3131 | 10.725 |
| 03:18 ET | 15966 | 10.71 |
| 03:20 ET | 3580 | 10.705 |
| 03:21 ET | 7602 | 10.705 |
| 03:23 ET | 27467 | 10.725 |
| 03:25 ET | 2862 | 10.73 |
| 03:27 ET | 16213 | 10.725 |
| 03:30 ET | 9443 | 10.725 |
| 03:32 ET | 7616 | 10.735 |
| 03:34 ET | 10266 | 10.73 |
| 03:36 ET | 5519 | 10.7288 |
| 03:38 ET | 6896 | 10.725 |
| 03:39 ET | 3655 | 10.725 |
| 03:41 ET | 8449 | 10.725 |
| 03:43 ET | 10232 | 10.72 |
| 03:45 ET | 39426 | 10.735 |
| 03:48 ET | 7496 | 10.7399 |
| 03:50 ET | 13030 | 10.72 |
| 03:52 ET | 32027 | 10.715 |
| 03:54 ET | 66579 | 10.685 |
| 03:56 ET | 57396 | 10.675 |
| 03:57 ET | 88980 | 10.685 |
| 03:59 ET | 635848 | 10.69 |
May 31, 2024
DJ Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 6:49AM ET on Friday May 31, 2024 by Dow Jones
6:49AM ET on Friday May 31, 2024 by Dow Jones
May 30, 2024
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update, from 7:00AM ET on Thursday May 30, 2024 by Dow Jones
7:00AM ET on Thursday May 30, 2024 by Dow JonesPress Release: Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update, from 7:00AM ET on Thursday May 30, 2024 by Dow Jones
7:00AM ET on Thursday May 30, 2024 by Dow Jones
May 28, 2024
DJ S&P 500 Futures Rise In Premarket Trading; GameStop, Jackson Financial Lead, from 7:30AM ET on Tuesday May 28, 2024 by Dow Jones
7:30AM ET on Tuesday May 28, 2024 by Dow Jones
May 24, 2024
DJ S&P 500 Futures Climb In Premarket Trading; Workday, Exact Sciences Lag, from 7:30AM ET on Friday May 24, 2024 by Dow Jones
7:30AM ET on Friday May 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 7.9B | 2.1x | --- |
Ligand Pharmaceuticals Inc | 1.4B | 15.3x | -12.71% |
Immunocore Holdings PLC | 1.9B | -32.1x | --- |
Corcept Therapeutics Inc | 3.0B | 27.1x | +9.80% |
Avadel Pharmaceuticals PLC | 1.5B | -8.5x | --- |
Harrow Inc | 635.8M | -19.8x | --- |
Company Information
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immunology and includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; batoclimab and IMVT-1402, fully human monoclonal antibodies targeting the neonatal Fc receptor in development across several IgG-mediated autoimmune indications; and brepocitinib, a TYK2/JAK1 inhibitor in late stage development for dermatomyositis, non-infectious uveitis, and other autoimmune conditions, in addition to other clinical-stage molecules. It advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Contact Information
- Headquarters
- 11-12 St. James's Square Suite 1, 3rd FloorLONDON, United Kingdom SW1Y4LB
- Phone
- 207-400-3347
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ilan Oren
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer
- Mayukh Sukhatme
- Chief Executive Officer, Director
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.9B |
|---|---|
Revenue (TTM) | $124.8M |
Shares Outstanding | 738.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $5.07 |
Book Value | $7.40 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | 63.3 |
Price/Cash Flow (TTM) | 1.9x |
Operating Margin | 3,425.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
